Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial co-expression and cell-cell communication inference from spatially resolved transcriptomics with CONCISE.

bioRxiv : the preprint server for biology·2026
Same author

Multimodal Sequencing and Reanalysis Approaches to End the Diagnostic Odyssey of Individuals with Suspected Rare Monogenic Diseases.

Genes·2026
Same author

Epistasis plays a limited role in driving entrenchment during neutral protein evolution.

Genome biology·2026
Same author

A unified framework for selecting and evaluating cell-type-specific gene co-expressions in single-cell data.

Briefings in bioinformatics·2026
Same author

MIXPRS enables multi-population and multi-method polygenic risk scores using summary statistics.

Nature genetics·2026
Same author

Empowering Inference of Epistasis on the Basis of Mutual Exclusivity, Co-Occurrence, Functional Antagonism and Synergy in ERK-Pathway Oncogenes.

International journal of cancer·2026

Related Experiment Video

Updated: Nov 11, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.8K

Identifying modules of cooperating cancer drivers.

Michael I Klein1,2, Vincent L Cannataro3,4, Jeffrey P Townsend1,4,5

  • 1Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA.

Molecular Systems Biology
|March 26, 2021
PubMed
Summary
This summary is machine-generated.

Cancer Rule Set Optimization (CRSO) identifies cooperating driver gene combinations driving tumor formation. This method reveals novel cancer driver insights and potential therapeutic targets across multiple cancer types.

Keywords:
cancer etiologydriver-gene combinationsmulti-gene biomarkerspatient stratificationprecision oncology

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.4K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.6K

Related Experiment Videos

Last Updated: Nov 11, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.8K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.4K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.6K

Area of Science:

  • Oncology
  • Computational Biology
  • Genomics

Background:

  • Identifying cooperating driver alterations is crucial for understanding cancer etiology and developing personalized treatments.
  • Current methods may not fully capture the complexity of driver gene interactions in tumorigenesis.

Purpose of the Study:

  • To present Cancer Rule Set Optimization (CRSO), a novel computational method for inferring cooperating driver alteration combinations in individual cancer patients.
  • To apply CRSO to TCGA data to identify core driver combinations and assess their prevalence and clinical relevance.

Main Methods:

  • CRSO algorithm development for inferring driver combinations.
  • Application of CRSO to 19 The Cancer Genome Atlas (TCGA) cancer types.
  • Comparison of CRSO with statistical co-occurrence methods.

Main Results:

  • CRSO identified a mean of 11 core driver combinations per cancer type, involving 2-6 alterations each, explaining a mean of 70% of samples.
  • CRSO detected known driver combinations missed by other methods and nominated novel ones correlating with clinical outcomes.
  • Novel NRAS-mutant melanoma synergies and NFE2L2-mutation-driven combinations in four cancer types were identified.

Conclusions:

  • CRSO provides a robust approach for uncovering cooperating driver modules in cancer.
  • The identified driver combinations offer insights into cancer etiology and nominate potential therapeutic strategies, including NRF2 pathway inhibition.